Overcoming the accuracy-generalization tradeoff in docking and scoring for prospective virtual screening
Garik Petrosyan, Vahagn AltunyaniD, Tsolak GhukasyaniD, Tigran M. AbramyaniD, Grigor ArakeloviD, Aram DavtyaniD, Tigran Aghajanyan, Iskander Nakipov, Gagik Navasardyan, Arman Fahradyan, Hazarapet Tunanyan, Arman SimonyaniD, Paweł JanczykiD, DAS Silva, Hayk Saribekyan, Lev Tsidilkovski, Vahram ArakeloviD, Narek Ginoyan, Hasmik Mnatsakanyan, Max Ratnikov, Khachik SmbatyaniD, Ashot Papoyan, Garegin A. PapoianiD
Abstract
Virtual screening promises access to tens of billions of synthetically accessible, diverse compounds, yet it is rarely used as a primary hit-discovery strategy in contemporary drug-discovery campaigns. We argue that this gap reflects the real-world underperformance of the underlying docking and scoring methods: classical docking is generalizable but limited in accuracy by simple functional forms and parsimonious parameterization, whereas recent machine-learning approaches are highly expressive but do not generalize well to novel molecules and pockets, their reported accuracy often inflated by train-test leakage. To address these challenges, we introduce DODock and DOScore, docking and scoring ML/physics hybrid frameworks that are also highly expressive, yet generalize much better out of distribution compared with the prior ML approaches. This generalization has been prospectively tested in several ways. First, DODocks blind prediction of a drug candidate binding to PCSK9 was compared to the crystal structure that was subsequently solved, recovering the binding pose to 1.2 [A] RMSD. We also used DODock and DOScore in prospective virtual screening campaigns against four therapeutic targets, spanning an ectoenzyme (CD73), a kinase (IRAK4), an extended-substrate protease (FXI), and an allosteric inhibition of protein-protein interface (IL17). These screens yielded many chemically novel, biochemically and cellularly active inhibitors. In the case of CD73, which is a historically challenging target for virtual screening, our screen resulted in a roughly hundredfold improvement in hit rate over a recent machine-learning screen. Our results indicate that the apparent ceiling in the accuracy of virtual screening that seemed to have somewhat plateaued in the last two decades is not fundamental, and that structure-based interrogation of ultralarge chemical space may eventually become a credible primary route to novel chemical matter.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Machine learning classification can reduce false positives in structure-based virtual screening
Yusuf O. Adeshina, Eric J. Deeds, John Karanicolas·Proceedings of the National Academy of SciencesPeer-reviewed·Jul 15, 2020
- NeuralDock: Rapid and conformation-agnostic docking of small molecules
C. M. Sha, J. Wang, N. V. Dokholyan·bioRxiv·Aug 20, 2021
- Deep Docking - a Deep Learning Approach for Virtual Screening of Big Chemical Datasets
Francesco Gentile, Vibudh Agrawal, … Artem R Cherkasov·ACS Central SciencePeer-reviewed·May 19, 2020
- ArtiDock: accurate Machine Learning approach to protein-ligand docking optimized for high-throughput virtual screening
Taras Voitsitskyi, Ihor Koleiev, … Алан Нафієв·Journal of Chemical Information and ModelingPeer-reviewed·Jan 30, 2026
- CompScore: boosting structure-based virtual screening performance by incorporating docking scoring functions components into consensus scoring
Yunierkis Pérez‐Castillo, Stellamaris Sotomayor-Burneo, … Eduardo Tejera·Journal of Chemical Information and ModelingPeer-reviewed·Aug 26, 2019
- Blind Virtual Screening at Scale: A Scalable End-to-End Pipeline for Blind Docking and Affinity Prediction
Matthew Parks, Xin Yu, … Hok Hei Tam·bioRxiv·Oct 10, 2025